Global Antidiabetic Drugs Market Size, Status and Forecast 2019-2025

Published On: May 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 275914

In 2018, the global Antidiabetic Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Antidiabetic Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antidiabetic Drugs development in United States, Europe and China.

The key players covered in this study
Eli Lilly
Novartis
Boehringer Ingelheim
Merck
Novo Nordisk
Sanofi
AstraZeneca
Takeda
Bayer
Pfizer

Market segment by Type, the product can be split into
Oral Drugs
Injectable Drugs

Market segment by Application, split into
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes Mellitus
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antidiabetic Drugs status, future forecast, growth opportunity, key market and key players.
To present the Antidiabetic Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Antidiabetic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Antidiabetic Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Drugs
1.4.3 Injectable Drugs
1.5 Market by Application
1.5.1 Global Antidiabetic Drugs Market Share by Application (2014-2025)
1.5.2 Type 1 Diabetes
1.5.3 Type 2 Diabetes
1.5.4 Gestational Diabetes Mellitus
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Antidiabetic Drugs Market Size
2.2 Antidiabetic Drugs Growth Trends by Regions
2.2.1 Antidiabetic Drugs Market Size by Regions (2014-2025)
2.2.2 Antidiabetic Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Antidiabetic Drugs Market Size by Manufacturers
3.1.1 Global Antidiabetic Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Antidiabetic Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Antidiabetic Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Antidiabetic Drugs Key Players Head office and Area Served
3.3 Key Players Antidiabetic Drugs Product/Solution/Service
3.4 Date of Enter into Antidiabetic Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Antidiabetic Drugs Market Size by Type (2014-2019)
4.2 Global Antidiabetic Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Antidiabetic Drugs Market Size (2014-2019)
5.2 Antidiabetic Drugs Key Players in United States
5.3 United States Antidiabetic Drugs Market Size by Type
5.4 United States Antidiabetic Drugs Market Size by Application

6 Europe
6.1 Europe Antidiabetic Drugs Market Size (2014-2019)
6.2 Antidiabetic Drugs Key Players in Europe
6.3 Europe Antidiabetic Drugs Market Size by Type
6.4 Europe Antidiabetic Drugs Market Size by Application

7 China
7.1 China Antidiabetic Drugs Market Size (2014-2019)
7.2 Antidiabetic Drugs Key Players in China
7.3 China Antidiabetic Drugs Market Size by Type
7.4 China Antidiabetic Drugs Market Size by Application

8 Japan
8.1 Japan Antidiabetic Drugs Market Size (2014-2019)
8.2 Antidiabetic Drugs Key Players in Japan
8.3 Japan Antidiabetic Drugs Market Size by Type
8.4 Japan Antidiabetic Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Antidiabetic Drugs Market Size (2014-2019)
9.2 Antidiabetic Drugs Key Players in Southeast Asia
9.3 Southeast Asia Antidiabetic Drugs Market Size by Type
9.4 Southeast Asia Antidiabetic Drugs Market Size by Application

10 India
10.1 India Antidiabetic Drugs Market Size (2014-2019)
10.2 Antidiabetic Drugs Key Players in India
10.3 India Antidiabetic Drugs Market Size by Type
10.4 India Antidiabetic Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Antidiabetic Drugs Market Size (2014-2019)
11.2 Antidiabetic Drugs Key Players in Central & South America
11.3 Central & South America Antidiabetic Drugs Market Size by Type
11.4 Central & South America Antidiabetic Drugs Market Size by Application

12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Antidiabetic Drugs Introduction
12.1.4 Eli Lilly Revenue in Antidiabetic Drugs Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Antidiabetic Drugs Introduction
12.2.4 Novartis Revenue in Antidiabetic Drugs Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Details
12.3.2 Company Description and Business Overview
12.3.3 Antidiabetic Drugs Introduction
12.3.4 Boehringer Ingelheim Revenue in Antidiabetic Drugs Business (2014-2019)
12.3.5 Boehringer Ingelheim Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Antidiabetic Drugs Introduction
12.4.4 Merck Revenue in Antidiabetic Drugs Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Novo Nordisk
12.5.1 Novo Nordisk Company Details
12.5.2 Company Description and Business Overview
12.5.3 Antidiabetic Drugs Introduction
12.5.4 Novo Nordisk Revenue in Antidiabetic Drugs Business (2014-2019)
12.5.5 Novo Nordisk Recent Development
12.6 Sanofi
12.6.1 Sanofi Company Details
12.6.2 Company Description and Business Overview
12.6.3 Antidiabetic Drugs Introduction
12.6.4 Sanofi Revenue in Antidiabetic Drugs Business (2014-2019)
12.6.5 Sanofi Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Antidiabetic Drugs Introduction
12.7.4 AstraZeneca Revenue in Antidiabetic Drugs Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 Takeda
12.8.1 Takeda Company Details
12.8.2 Company Description and Business Overview
12.8.3 Antidiabetic Drugs Introduction
12.8.4 Takeda Revenue in Antidiabetic Drugs Business (2014-2019)
12.8.5 Takeda Recent Development
12.9 Bayer
12.9.1 Bayer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Antidiabetic Drugs Introduction
12.9.4 Bayer Revenue in Antidiabetic Drugs Business (2014-2019)
12.9.5 Bayer Recent Development
12.10 Pfizer
12.10.1 Pfizer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Antidiabetic Drugs Introduction
12.10.4 Pfizer Revenue in Antidiabetic Drugs Business (2014-2019)
12.10.5 Pfizer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details